Skip to main content

Corporate News tagged:

3D cell culture

REPROCELL Corporate News

Dates: 19-20 February 2020 Venue: Copthorne Tara, London, United Kingdom Website: https://www.smi-online.co.uk/pharmaceuticals/uk/3D-Cell-Culture REPROCELL Europe’s CSO Professor Stefan Przyborski...

The SMi Group’s conference on 3D Cell Culture will be held on 21-22 February 2018.The venue is the Copthorne Tara Hotel in Kensington, London, UK. Find out more at www.3d-CellCulture.com REPROCELL...

REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, was in Durham University (UK) News. Developed at the university by Professor Stefan Prsyborski, Alvetex was first...

Scotland’s Life Sciences Dinner was held on 2nd February 2017 at the National Museum of Scotland. The event was attended by CEO and Chairman of REPROCELL Inc, Dr Chikafumi Yokoyama, as well as senior...

The SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb) will be chaired by REPROCELL Europe’s chief scientific officer (CSO), Professor Stefan Przyborski. He will also be giving the first lecture...

REPROCELL Europe has won the Corporate Vision Technology Innovation Award 2016 for Alvetex technology for 3D cell culture. The following is CV Magazine’s interview with REPROCELL Europe’s CSO...

ReproCELL Europe Ltd’s Chief Scientific Officer Prof Stefan Przyborski is giving a public lecture on “Scaffold Cell Culture Technology for Generation of In Vivo-like Tissue Models” at the British...

Professor Stefan Przyborski, Chief Scientific Officer of REPROCELL Europe (formerly Reinnervate), is to give a seminar on Alvetex next week, 24th May 2016. Venue: Large Lecture Theatre Le Gros Clark...

We are pleased to announce that Reinnervate Ltd has been awarded Corporate Vision’s 2015 Technology Innovator Award for Alvetex 3D cell culture. Alvetex has been awarded the title, “Most Advanced 3D...

Alvetex in Space

14 January 2016

While the first British ESA astronaut Tim Peake is currently on the International Space Station (ISS) and is about to make his first spacewalk, now is a good time to mention again that Reinnervate’s...

Notice concerning the publication of a paper concerning “3D culture model construction of mouse neurons” from a company in our group in the international neuroscience journal ‘Neuroscience Letters’...

Company: REPROCELL, Inc. (JASDAQ Company code: 4978) Representative: Chikafumi Yokoyama, PhD Contact: info-emea@reprocell.com We are pleased to announce that a research report on “3D Skin Model...

Sedgefield, UK. April 2015 – Market leading 3D cell culture company Reinnervate Ltd, part of the ReproCELL group, today announced that a rocket carrying its Alvetex® Scaffold technology blasted into...

Scientists at AstraZeneca in the UK have compared the activity of a diverse compound set in 2D and 3D cell cultures using Alvetex® Scaffold 384 well plates in an automated Oncology HTS (High...

YOKOHAMA, Japan — REPROCELL (JASDAQ:4978) announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. This acquisition allows the REPROCELL Group to expand the product lineups of its...

Location: REPROCELL Inc. (Yokohama, Japan) Date: August 5, 2014 The Japanese regenerative medicine company REPROCELL Inc. has announced the acquisition of Reinnervate Ltd. (UK), one of the leading...

Reinnervate today announced the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media. This product allows scientists to create cell based...

Sedgefield, UK. November 2013 – 3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO’s to offer 3D tumour cell screening services. The CROs, Oncotest...

Sedgefield, UK. September 2013 – Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D...

Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course, which will be held on 7-8 November 2013 at their new premises in the Sci-Tech...